Pelvic Floor Exercise Before Surgery in Women With Pelvic Organ Prolapse (CONTRAPOP)

December 2, 2021 updated by: St. Olavs Hospital

The lifetime risk for a woman to undergo surgery for either vaginal prolapse or urinary incontinence is high. There are many different surgical techniques for treatment of prolapse, but there is a lack of knowledge about factors that contribute to objective result and patient satisfaction after surgery.

The aim of the study is to investigate factors that could be related to patient satisfaction and objective result such as pelvic floor muscle contractility/strength and muscle injury, objective measures of prolapse and women's symptoms. This study will investigate whether systematic pelvic floor exercise and life style advise before surgery can improve outcomes after surgery for either vaginal prolapse. Another aim is to determine an ultrasound scale for measure of pelvic floor muscle contraction.

Study Overview

Study Type

Interventional

Enrollment (Actual)

151

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trondheim, Norway
        • St Olavs Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • referred to surgery for urogenital prolapse
  • informed consent

Exclusion Criteria:

  • not able to communicate in Norwegian or English
  • not able or willing to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pre-surgery exercise
pelvic floor exercises individually and in groups
In preparation for surgery, patients receive individual information by a physiotherapist on pelvic floor anatomy and correct pelvic floor contraction. Patients are told to do the following pelvic floor exercises 3 times a day: 8-12 maximal contractions, hold contractions during 10 seconds, and 3 fast contractions after each long contraction. In addition exercise in groups with skilled physical therapists once a week during 12 weeks.
Other: Waiting list
wait as usual until surgery
patients wait as usual until surgery without special treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic floor muscle strength assessed by palpation
Time Frame: 9 months
Muscle strength is evaluated using 6 point modified Oxford Scale (MOS) range 0-5.
9 months
Pelvic floor muscle strength assessed by ultrasound
Time Frame: 9 months
Changes in pelvic floor muscle at rest and during pelvic floor contraction, measured in mm and calculated proportional change
9 months
Symptoms of pelvic floor disorders
Time Frame: 9 months
Symptoms of pelvic floor disorders assessed by validated questionnaire (PDFI-20)
9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic floor muscle strength assessed by perineometry
Time Frame: 9 months
measuring the pressure with vaginal manometry in cm H2O during pelvic floor contraction
9 months
Pelvic floor muscle strength assessed by electromyography
Time Frame: 9 months
Assessed by vaginal surface electrode during pelvic floor contraction, measured in mV
9 months
Proportion of anatomical pelvic organ prolapse
Time Frame: 9 months
Assessment with the Pelvic Organ Prolapse Quantification (POP-Q) System
9 months
Proportion of anatomical sphincter ani defect
Time Frame: 9 months
Anatomical sphincter ani defect assessed by transperineal ultrasound
9 months
Proportion of levator ani muscle trauma
Time Frame: 9 months
Assessed by transperineal ultrasound on contraction and Valsalva
9 months
Assessment of pelvic organ mobility as a measure of pelvic organ function/dysfunction
Time Frame: 9 months
Movement of the pelvic organs during Valsalva and contraction
9 months
Imaging of synthetic implants assessed by ultrasound
Time Frame: 9 months
Registration of implants after pelvic floor surgery and their relations to anatomical structures in mm.
9 months
Symptoms of pelvic floor disorders
Time Frame: 9 months
Symptoms of pelvic floor disorders assessed by validated questionnaire (PFIQ-7)
9 months
Symptoms of pelvic floor disorders
Time Frame: 9 months
Symptoms of pelvic floor disorders assessed by visual analogue scale (VAS 1-10)
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Kjell Å Salvesen, md prof, St Olavs Hospital University Hospital Trondheim

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

June 26, 2019

Study Completion (Actual)

June 26, 2019

Study Registration Dates

First Submitted

February 22, 2017

First Submitted That Met QC Criteria

February 22, 2017

First Posted (Actual)

February 27, 2017

Study Record Updates

Last Update Posted (Actual)

December 17, 2021

Last Update Submitted That Met QC Criteria

December 2, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe